...
首页> 外文期刊>Letters in drug design & discovery >Design, Synthesis and Biological Evaluation of 4-(Imidazolylmethyl)-2-Aryl-Quinoline Derivatives as Aromatase Inhibitors and Anti-breast Cancer Agents
【24h】

Design, Synthesis and Biological Evaluation of 4-(Imidazolylmethyl)-2-Aryl-Quinoline Derivatives as Aromatase Inhibitors and Anti-breast Cancer Agents

机译:4-(咪唑基甲基)-2-芳基-喹啉衍生物作为芳香化酶抑制剂和抗乳腺癌药物的设计,合成和生物学评价

获取原文
获取原文并翻译 | 示例
           

摘要

Some new quinoline derivatives were designed and synthesized to evaluate their biological activities as aromatase inhibitors and anti-breast cancer agents. Cytotoxicity of quinolines 8a-g against human breast cancer MCF-7 and T47D cell lines were evaluated. All the compounds 8a-g were more cytotoxic against MCF-7 cells in comparison with those of T47D which express aromatase mRNA less than MCF-7 cells. Their effects on Aromatase activity are also described. Our results showed that compound 8b inhibits aromatase enzyme activity more than reference drug Letrozol.
机译:设计并合成了一些新的喹啉衍生物,以评估其作为芳香酶抑制剂和抗乳腺癌药物的生物学活性。评估喹啉8a-g对人乳腺癌MCF-7和T47D细胞系的细胞毒性。与表达芳香化酶mRNA的MCF-7细胞相比,T47D的化合物8a-g对MCF-7细胞的细胞毒性更高。还描述了它们对芳香酶活性的影响。我们的结果表明,化合物8b比参考药物来曲唑抑制芳香酶的活性更大。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号